Expand PLYX Menu
PLYX MENU

PLYX Latest Press Releases

-- May 28, 2026 --

Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial Globe Newswire 8:30 AM

-- May 14, 2026 --

Polaryx Therapeutics Receives GHP Magazine's Healthcare & Pharmaceuticals Awards Globe Newswire 9:15 AM

-- April 23, 2026 --

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference Globe Newswire 8:33 AM
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference Globe Newswire 8:33 AM

-- April 21, 2026 --

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial Globe Newswire 8:30 AM

-- April 15, 2026 --

Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care Globe Newswire 9:15 AM

-- April 1, 2026 --

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference Globe Newswire 8:30 AM

-- March 17, 2026 --

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX-200 for Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease) Globe Newswire 8:30 AM

-- March 12, 2026 --

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events Globe Newswire 8:30 AM

-- February 27, 2026 --

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders Globe Newswire 8:30 AM

-- February 17, 2026 --

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial Globe Newswire 8:30 AM

-- February 10, 2026 --

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes